Pulmonology Medical News about Pleural Effusion

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Monoclonal anti-vascular endothelial growth factor antibody reduces fluid volume in an experimental model of inflammatory pleural effusion
Respirology, 10/12/09

Ribeiro SCC et al. – This study showed that bevacizumab interferes in the acute phase of pleural inflammation induced by silver nitrate or talc, reinforcing the role of VEGF as a key mediator in the production of pleural effusions. The results also suggest that bevacizumab should probably be avoided in patients requiring pleurodesis.

<< Previous
Effects of Sleep Fragmentation on Glucose Metabolism in Normal...

Next >>
The Saudi Initiative for asthma

Dasatinib-Induced Pleural Effusions: A Lymphatic Network Disorder
The American Journal of the Medical Sciences, 11/13/09 Relevance Score: 70%

A systematic approach to the investigation and diagnosis of a unilateral pleural effusion
International Journal of Clinical Practice, 10/15/09 Relevance Score: 68%

Usefulness of pneumococcal antigen detection in pleural effusion for the rapid diagnosis of infection by Streptococcus pneumoniae
European Journal of Pediatrics, 10/13/09 Relevance Score: 66%

Pleural effusion from a candy wrapper
Cleveland Clinic Journal of Medicine, 11/04/09 Relevance Score: 65%

Treatment of Malignant Pleural Effusion: PleuRx Catheter or Talc Pleurodesis? A Cost-Effectiveness Analysis
Journal of Palliative Medicine, 10/30/09 Relevance Score: 65%